
CRISPR Therapeutics AG: shareholders and insiders
Price
$39.10
November 20, 2026Market cap $3.8B
What Ploutos Investor adds for CRISPR Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from 2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 22% since Nov 2, 2026, when the 10-Q these figures come from was filed ($49.99 then, $39.10 on Nov 20, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- ARK Investment Management LLCwith 1 more personShare of class11.8%
- BlackRock, Inc.Share of class8.30%
- Orbis Investment Managementwith 1 more personShare of class5.60%
- State StreetShare of class5.20%
- Capital World InvestorsShare of class5.10%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| ARK Investment Management LLCwith 1 more person | 11.8% | 11.31M | Apr 30, 20265 filings since Jan 10, 2025 | 13G/A | |
| BlackRock, Inc. | 8.30% | 7.99M | Jul 27, 20262 filings since Jul 17, 2025 | 13G/A | |
| Orbis Investment Managementwith 1 more person | 5.60% | 5.43M | Aug 14, 20264 filings since Nov 14, 2025 | 13G/A | |
| State Street | 5.20% | 4.99M | Nov 10, 2026 | 13G | |
| Capital World Investors | 5.10% | 4.93M | May 14, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Capital International Investors1.20%Feb 5, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- D.E. ShawIn the quarter-42%
- Citadel Advisors (Griffin)In the quarter-99%
- Millennium Mgmt (Englander)In the quarter-76%
- AQR CapitalIn the quarter+47%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| D.E. Shaw | 518.9K | -42% | $29M | 0.02% |
| Citadel Advisors (Griffin) | 4,680 | -99% | $300.0K | 0.00% |
| Millennium Mgmt (Englander) | 91.6K | -76% | $5.1M | 0.00% |
| AQR Capital | 41.9K | +47% | $2.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 17.1% of its shares outstanding were held short, -12.0% since the report before.
- Shares held short
- 16.44M
- 17.1%
- Since the report before18.68M on Sep 30, 2026
- -12.0%
- 10.2
- 1.61M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 92%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 13.89M
- Nov 15, 2023: Shares held short 16.37M
- Nov 30, 2023: Shares held short 15.93M
- Dec 15, 2023: Shares held short 17.33M
- Dec 29, 2023: Shares held short 16.25M
- Jan 12, 2024: Shares held short 17.04M
- Jan 31, 2024: Shares held short 15.74M
- Feb 15, 2024: Shares held short 14.87M
- Feb 29, 2024: Shares held short 15.06M
- Mar 15, 2024: Shares held short 14.72M
- Mar 28, 2024: Shares held short 14.76M
- Apr 15, 2024: Shares held short 14.74M
- Apr 30, 2024: Shares held short 14.59M
- May 15, 2024: Shares held short 15.33M
- May 31, 2024: Shares held short 15.66M
- Jun 14, 2024: Shares held short 14.87M
- Jun 28, 2024: Shares held short 15.65M
- Jul 15, 2024: Shares held short 16.12M
- Jul 31, 2024: Shares held short 16.43M
- Aug 15, 2024: Shares held short 17.17M
- Aug 30, 2024: Shares held short 17.44M
- Sep 13, 2024: Shares held short 17.54M
- Sep 30, 2024: Shares held short 17.56M
- Oct 15, 2024: Shares held short 17.59M
- Oct 31, 2024: Shares held short 18.59M
- Nov 15, 2024: Shares held short 19.39M
- Nov 29, 2024: Shares held short 18.15M
- Dec 13, 2024: Shares held short 18.12M
- Dec 31, 2024: Shares held short 19.10M
- Jan 15, 2025: Shares held short 20.31M
- Jan 31, 2025: Shares held short 19.49M
- Feb 14, 2025: Shares held short 20.41M
- Feb 28, 2025: Shares held short 20.81M
- Mar 14, 2025: Shares held short 20.31M
- Mar 31, 2025: Shares held short 20.51M
- Apr 15, 2025: Shares held short 20.76M
- Apr 30, 2025: Shares held short 21.32M
- May 15, 2025: Shares held short 21.07M
- May 30, 2025: Shares held short 20.54M
- Jun 13, 2025: Shares held short 21.41M
- Jun 30, 2025: Shares held short 25.54M
- Jul 15, 2025: Shares held short 25.30M
- Jul 31, 2025: Shares held short 23.45M
- Aug 15, 2025: Shares held short 23.31M
- Aug 29, 2025: Shares held short 22.07M
- Sep 15, 2025: Shares held short 23.81M
- Sep 30, 2025: Shares held short 21.35M
- Oct 15, 2025: Shares held short 21.05M
- Oct 31, 2025: Shares held short 21.03M
- Nov 14, 2025: Shares held short 23.19M
- Nov 28, 2025: Shares held short 22.43M
- Dec 15, 2025: Shares held short 21.86M
- Dec 31, 2025: Shares held short 21.05M
- Jan 15, 2026: Shares held short 21.74M
- Jan 30, 2026: Shares held short 21.89M
- Feb 13, 2026: Shares held short 22.64M
- Feb 27, 2026: Shares held short 21.56M
- Mar 13, 2026: Shares held short 21.69M
- Mar 31, 2026: Shares held short 22.62M
- Apr 15, 2026: Shares held short 22.75M
- Apr 30, 2026: Shares held short 22.48M
- May 15, 2026: Shares held short 27.29M
- May 29, 2026: Shares held short 21.67M
- Jun 15, 2026: Shares held short 26.57M
- Jun 30, 2026: Shares held short 20.40M
- Jul 15, 2026: Shares held short 19.81M
- Jul 31, 2026: Shares held short 18.82M
- Aug 14, 2026: Shares held short 18.74M
- Aug 31, 2026: Shares held short 18.77M
- Sep 15, 2026: Shares held short 19.07M
- Sep 30, 2026: Shares held short 18.68M
- Oct 15, 2026: Shares held short 16.44M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading55.9% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 55.9% of the shares in the reported trades were short sales, against 60.0% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 55.9%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 60.0%
- Change
- -4.1 pts
- Short sales a dayon average, of 968.8K shares
- 541.4K
- More than atof 3,666 US-listed companies, same days
- 70%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 67.8%
- Oct 15, 2026: Short sales 51%
- Oct 16, 2026: Short sales 62.9%
- Oct 19, 2026: Short sales 55.8%
- Oct 20, 2026: Short sales 63%
- Oct 21, 2026: Short sales 52.6%
- Oct 22, 2026: Short sales 50.7%
- Oct 23, 2026: Short sales 83.1%
- Oct 26, 2026: Short sales 64.4%
- Oct 27, 2026: Short sales 48.3%
- Oct 28, 2026: Short sales 46.7%
- Oct 29, 2026: Short sales 43.2%
- Oct 30, 2026: Short sales 50.2%
- Nov 2, 2026: Short sales 59.6%
- Nov 3, 2026: Short sales 49.5%
- Nov 4, 2026: Short sales 60.2%
- Nov 5, 2026: Short sales 51.4%
- Nov 6, 2026: Short sales 51.9%
- Nov 9, 2026: Short sales 44.9%
- Nov 10, 2026: Short sales 44.8%
- Nov 11, 2026: Short sales 33.8%
- Nov 12, 2026: Short sales 44.8%
- Nov 13, 2026: Short sales 53.2%
- Nov 16, 2026: Short sales 70.2%
- Nov 17, 2026: Short sales 77.2%
- Nov 18, 2026: Short sales 72.3%
- Nov 19, 2026: Short sales 59.5%
- Nov 20, 2026: Short sales 59.6%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- ARKGARK Genomic Revolution ETFWeight in the fund6.29%
- ARKKARK Innovation ETFWeight in the fund4.73%
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund1.02%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.66%
- IBBiShares Biotechnology ETFWeight in the fund0.38%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.29%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.17%
- IWMiShares Russell 2000 ETFWeight in the fund0.16%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.12%
- SCHMSchwab U.S. Mid-Cap ETFWeight in the fund0.10%
20 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 442
- Q4 2025: Managers 480
- Q1 2026: Managers 495
- Q2 2026: Managers 523
Institutional investors by quarter
The fund managers holding CRSP, quarter by quarter, from Q1 2016 to Q2 2025, 36 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 523 managers held 76.29M shares, worth $4.2B. During the quarter 81 opened a position, 53 closed one, 152 added and 140 trimmed.
The largest holders, Q2 2026
- ARK Investment ManagementIn the quarter-16%
- BlackRockIn the quarter+8.7%
- Orbis Allan GrayIn the quarter-11%
- Capital World InvestorsIn the quarter+0.5%
- State StreetIn the quarter+8.5%
- GskIn the quarter
- Geode Capital ManagementIn the quarter+5.6%
- T. Rowe Price Investment ManagementIn the quarter-30%
- SR One Capital ManagementIn the quarter
- Two Sigma InvestmentsIn the quarter+34%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| ARK Investment Management | 9.46M | -16% | $516M |
| BlackRock | 8.35M | +8.7% | $455M |
| Orbis Allan Gray | 5.45M | -11% | $297M |
| Capital World Investors | 4.75M | +0.5% | $259M |
| State Street | 4.32M | +8.5% | $236M |
| Gsk | 3.22M | $176M | |
| Geode Capital Management | 2.51M | +5.6% | $137M |
| T. Rowe Price Investment Management | 2.05M | -30% | $112M |
| SR One Capital Management | 2.04M | $111M | |
| Two Sigma Investments | 1.99M | +34% | $108M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do CRISPR Therapeutics's filings show?
Who buys and sells is one part of CRISPR Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold CRSP?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $29M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.